CIENCIASMEDICASNEWS: Alzheimer's Research & Therapy

Alzheimer's Research & Therapy is affiliated with Alzheimer's Disease International (ADI), London, United Kingdom.

Articles

Content Type:Research
| 27 December 2018
Comparative safety and effectiveness of cholinesterase inhibitors and memantine for Alzheimer’s disease: a network meta-analysis of 41 randomized controlled trials
Authors:Kai-Xin Dou, Meng-Shan Tan, Chen-Chen Tan, Xi-Peng Cao, Xiao-He Hou, Qi-Hao Guo, Lan Tan, Vincent Mok and Jin-Tai Yu
Content Type:Research
| 22 December 2018
The gut microbiota-derived metabolite trimethylamine N-oxide is elevated in Alzheimer’s disease
Authors:Nicholas M. Vogt, Kymberleigh A. Romano, Burcu F. Darst, Corinne D. Engelman, Sterling C. Johnson, Cynthia M. Carlsson, Sanjay Asthana, Kaj Blennow, Henrik Zetterberg, Barbara B. Bendlin and Federico E. Rey
Content Type:Research
| 22 December 2018
Reactions to learning a “not elevated” amyloid PET result in a preclinical Alzheimer’s disease trial
Authors:Joshua D. Grill, Chelsea G. Cox, Kristin Harkins and Jason Karlawish
Content Type:Research
| 20 December 2018
Brain and cognitive correlates of subjective cognitive decline-plus features in a population-based cohort
Authors:Gonzalo Sánchez-Benavides, Oriol Grau-Rivera, Marc Suárez-Calvet, Carolina Minguillon, Raffaele Cacciaglia, Nina Gramunt, Carles Falcon, Juan Domingo Gispert and José Luis Molinuevo
Content Type:Debate
| 19 December 2018
Heterogeneity of Alzheimer’s disease: consequence for drug trials?
Authors:Gayatri Devi and Philip Scheltens